Physician
Circle Health Urgent Care, LLC
Circle Health Urgent Care, LLC was paid $5.94M by Medicaid between Jan 2018 and Dec 2024, across 24 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 34% of everything it billed.
33Billing provider infoCIRCLE HEALTH URGENT CARE, LLC
WESTFORD, MA 01886
WESTFORD, MA 01886
33aNPI1710392683assigned 06/30/2014
33bProvider typeEmergency Medicine Physician
28Total paid$5.94M
24GClaims93,814
24DCodes billed24
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Massachusetts
Rank by total paid#11 of 618
Median peer was paid$8K
This provider vs. median719×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,192 | $71K | |
| 2019 | 5,242 | $271K | |
| 2020 | 8,091 | $454K | |
| 2021 | 23,087 | $1.25M | |
| 2022 | 14,415 | $1.08M | |
| 2023 | 21,357 | $1.40M | |
| 2024incomplete | 20,430 | $1.41M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 34% | 17,087 | 16,536 | $2.00M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 25,215 | 24,845 | $1.69M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 9,560 | 9,469 | $649K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.0% | 8,391 | 8,277 | $416K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.2% | 4,576 | 4,466 | $312K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.0% | 9,068 | 8,821 | $240K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.9% | 2,518 | 2,457 | $234K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 1,152 | 1,136 | $118K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.7% | 4,394 | 4,287 | $98K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 4,323 | 4,200 | $63K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 634 | 623 | $31K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,181 | 1,141 | $27K |
12 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,958 | $22K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 147 | $14K |
| 87081 | <1% | 1,292 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 528 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 113 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 110 | $4K |
| 81002 | <1% | 1,140 | $2K | |
| 81025 | <1% | 281 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 60 | $1K |
| 90686 | <1% | 34 | $531.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 36 | $261.59 |
| 82948 | <1% | 16 | $40.05 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCPADDEN, TRACIE (ASSOCIATE CHIEF NURSING OFFICER)
Parent organizationCIRCLE HEALTH PHYSICIANS, INC.